Other Oncology.TV sites:

  • Home
  • Continuing Education
  • Oncology TV Network
  • Ask The Experts
  • Symptom Management
  • Events
  • Links
Login | Register



All CE Courses Viewed Courses Completed Courses
The CME/CE courses at Oncology.tv cover a wide range of topics important to the practicing oncology health care provider. We invite you to browse through the menu below where you'll find programs on a wide range of disease states and related issues.
Recent  |   Popular                   Specialties:     
Currently viewing : Lecture Series
Holding Court in MPN: In PV, Should JAK Inhibitor Therapy Be Restricted to After Failure of Hydroxyurea? VIEW DETAILS  
Welcome to Holding Court in MPN, where leading experts in Myeloproliferative Neoplasms (MPNs) are the lawyers and witnesses, and you are the jury. This case considers the question “In PV, Should JAK Inhibitor Therapy Be Restricted to After Failure of Hydroxyurea?”

Credit Hours: 
0.75 AMA PRA Category 1 Credit™
0.8 ANCC contact hour

Estimated time to complete activity: 45 minutes
 Valid Until:
1/18/2018
   
Moderator (Judge):
Srdan Verstovsek, MD, PhD


 Date Released:
1/18/2017
    Fee:  
    FREE

Jointly provided by Postgraduate Institute for Medicine and Total CME

       
  

 
Holding Court in MPN: Should Low-risk MF Patients Be Treated With a JAK Inhibitor Upfront, or Save It for Later? VIEW DETAILS  
Welcome to Holding Court in MPN, where leading experts in Myeloproliferative Neoplasms (MPNs) are the lawyers and witnesses, and you are the jury. This case considers the question “Should Low-risk MF Patients Be Treated With a JAK Inhibitor Upfront, or Save It for Later?”

Credit Hours: 
0.75 AMA PRA Category 1 Credit™
0.6 ANCC contact hour

Estimated time to complete activity: 45 minutes
 Valid Until:
1/18/2018
   
Moderator (Judge):
Srdan Verstovsek, MD, PhD


 Date Released:
1/18/2017
    Fee:  
    FREE

Jointly provided by Postgraduate Institute for Medicine and Total CME

       
  

 
Holding Court in MPN: Is the Current PV Assessment System Adequate to Predict Outcomes and Guide Therapy? VIEW DETAILS  
Welcome to Holding Court in MPN, where leading experts in Myeloproliferative Neoplasms (MPNs) are the lawyers and witnesses, and you are the jury. This case considers the question “Is the Current PV Assessment System Adequate to Predict Outcomes and Guide Therapy?”

Credit Hours: 
0.75AMA PRA Category 1 Credit™
0.7 ANCC contact hour

Estimated time to complete activity: 45 minutes
 Valid Until:
1/18/2018
   
Moderator (Judge):
Srdan Verstovsek, MD, PhD


 Date Released:
1/18/2017
    Fee:  
    FREE

Jointly provided by Postgraduate Institute for Medicine and Total CME

       
  

 
Holding Court in MPN: Does Distinguishing Between WHO 2016 Prefibrotic (prePMF) and ET Matter? VIEW DETAILS  
Welcome to Holding Court in MPN, where leading experts in Myeloproliferative Neoplasms (MPNs) are the lawyers and witnesses, and you are the jury. This case considers the question “Does Distinguishing Between WHO 2016 Prefibrotic (prePMF) and ET Matter?”

Credit Hours: 
0.75 AMA PRA Category 1 Credit™
0.6 ANCC contact hour

Estimated time to complete activity: 45 minutes
 Valid Until:
1/18/2018
   
Moderator (Judge):
Srdan Verstovsek, MD, PhD


 Date Released:
1/18/2017
    Fee:  
    FREE

Jointly provided by Postgraduate Institute for Medicine and Total CME

       
  

 
Epidemiologic, Environmental, and Molecular Disparities in GI Cancer Among Hispanics VIEW DETAILS  
The following program was filmed at "Fighting a Smarter War Against Cancer", a Symposium presented by The Ruesch Center for the Cure of Gastrointestinal Cancers.
Credit Hours:
No credits of any type are currently available for this lecture
 Valid Until:
This lecture does not expire
   
Lecturer:
Marcia Cruz-Correa, MD, PhD, AGAF, FASGE
Professor of Medicine, Biochemistry
and Surgery
University of Puerto Rico Medical Sciences Campus
Adjunct Professor of Surgical Oncology MDACC
Adjunct Associate Professor of Medicine Johns Hopkins University
 Date Released:
01/16/2017
    Fee:  
    FREE  

 
Colorectal Cancer: Current “Standard” Uses for Molecular Testing VIEW DETAILS  
The following program was filmed at "Fighting a Smarter War Against Cancer", a Symposium presented by The Ruesch Center for the Cure of Gastrointestinal Cancers.
Credit Hours:
No credits of any type are currently available for this lecture
 Valid Until:
This lecture does not expire
   
Lecturer:
Michael Pishvaian, MD, PhD
Phase I Program Director
Co-Director of the Ruesch Cener Pancreatic Cancer Program
Assistant Professor
Lombardi Comprehensive Cancer Center
Georgetown University
 Date Released:
01/16/2017
    Fee:  
    FREE  

 
1 2 3 4 5 6 7 8 9 10 ...




ABOUT ONCOLOGY.TV

Previously known as OncUView.tv, the Oncology.TV family of medical education websites offers physicians, nurses, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about cancer and a variety of tumor types.

SOCIAL MEDIA
OTHER ONCOLOGY.TV SITES 

 
 

PARTNER SITES
 
Privacy Statement  |   Terms Of Use  |  Contact Oncology.TV  |   Copyright 2017 by Oncology.TV